Kaine pitches reforms for drug pricing program supporting underserved patients, safety net providers

U.S. Sen. Tim Kaine introduced legislation to reform the 340B federal drug pricing program, which provides prescription discounts to providers serving underserved patients. The bill includes annual reporting requirements, HHS auditing authority, and protections against rebate models to ensure smaller providers can access up-front discounts. The debate also involves Republican Sen. Bill Cassidy, who proposed a different rebate-based approach.